These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8824693)

  • 1. Effects of acute and chronic angiotensin converting enzyme inhibition by spirapril on cardiovascular regulation in essential hypertensive patients. Assessment by spectral analysis and haemodynamic measurements.
    Veerman DP; Douma CE; Jacobs MC; Thien T; Van Montfrans GA
    Br J Clin Pharmacol; 1996 Jan; 41(1):49-56. PubMed ID: 8824693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
    van den Meiracker AH; Man in 't Veld AJ; Admiraal PJ; Ritsema van Eck HJ; Boomsma F; Derkx FH; Schalekamp MA
    J Hypertens; 1992 Aug; 10(8):803-12. PubMed ID: 1325513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
    van den Broek SA; de Graeff PA; Smit AJ; Girbes AR; Journée ; van Gilst WH; Hillege H; van Veldhuisen DJ; Wesseling H; Lie KI
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):105-12. PubMed ID: 7723338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension.
    Petersen JR; Drabaek H; Gleerup G; Mehlsen J; Petersen LJ; Winther K
    Angiology; 1996 Mar; 47(3):233-40. PubMed ID: 8638865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic effects of spirapril, alone or in combination with isradipine on kidney function and blood pressure in patients with reduced kidney function and hypertension.
    Shohat J; Wittenberg C; Erman A; Rosenfeld J; Boner G
    Scand J Urol Nephrol; 1999 Feb; 33(1):57-62. PubMed ID: 10100366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of four different antihypertensive medications on cardiovascular regulation in hypertensive sleep apneic patients--assessment by spectral analysis of heart rate and blood pressure variability.
    Salo TM; Kantola I; Voipio-Pulkki LM; Pelttari L; Viikari JS
    Eur J Clin Pharmacol; 1999 May; 55(3):191-8. PubMed ID: 10379634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive effect of chronic converting enzyme inhibition on aortic stiffening induced by renovascular hypertension in conscious dogs.
    Fischer EI; Levenson J; Barra JG; Armentano RL; Pichel RH; Simon A
    Cardiovasc Res; 1993 Jun; 27(6):1039-44. PubMed ID: 8221761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term effects of spirapril on renal hemodynamics in patients with essential hypertension.
    Reams GP; Lau A; Knaus V; Bauer JH
    J Clin Pharmacol; 1993 Apr; 33(4):348-53. PubMed ID: 8473550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spirapril. A preliminary review of its pharmacology and therapeutic efficacy in the treatment of hypertension.
    Noble S; Sorkin EM
    Drugs; 1995 May; 49(5):750-66. PubMed ID: 7601014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute hemodynamic, hormonal, and pharmacokinetic properties of oral spirapril in patients with moderate to severe heart failure.
    van den Broek SA; van Bruggen A; de Graeff PA; Hillege H; van Gilst WH; Wesseling H; Lie KI
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):614-21. PubMed ID: 1724540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
    van Wijngaarden J; Pinto YM; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H
    Cardiovasc Res; 1991 Nov; 25(11):936-42. PubMed ID: 1813122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension.
    Nørgaard K; Jensen T; Christensen P; Feldt-Rasmussen B
    Blood Press; 1993 Dec; 2(4):301-8. PubMed ID: 8173700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autonomic function and baroreflex sensitivity during angiotensin-converting enzyme inhibition or angiotensin II AT-1 receptor blockade in essential hypertensive patients.
    Guasti L; Petrozzino MR; Mainardi LT; Grimoldi P; Zanotta D; Garganico D; Diolisi A; Simoni C; Grandi AM; Gaudio G; Cerutti S; Venco A
    Acta Cardiol; 2001 Oct; 56(5):289-95. PubMed ID: 11712824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic, pulmonary, brachial, renal and hepato-splanchnic hemodynamic effects of spirapril in severe congestive heart failure.
    Bellissant E; Annane D; Pussard E; Thuillez C; Giudicelli JF
    Fundam Clin Pharmacol; 1996; 10(2):127-35. PubMed ID: 8737955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of spirapril and hydrochlorothiazide on platelet function and euglobulin clot lysis time in patients with mild hypertension.
    Gleerup G; Petersen JR; Mehlsen J; Winther K
    Angiology; 1996 Oct; 47(10):951-5. PubMed ID: 8873580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and haemodynamic effects of a single oral dose of the novel ACE inhibitor spirapril in patients with chronic liver disease.
    Krähenbühl S; Grass P; Surve A; Kutz K; Reichen J
    Eur J Clin Pharmacol; 1993; 45(3):247-53. PubMed ID: 8276049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibition with spirapril in patients with coronary artery disease.
    Thürmann P; Rietbrock N
    Blood Press Suppl; 1994; 2():73-6. PubMed ID: 8061851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of spirapril, a new ace-inhibitor, in elderly hypertensive patients.
    Kantola I; Terént A; Honkanen T; Järveläinen V; Ekman K; Kataja M
    Eur J Clin Pharmacol; 1996; 50(3):155-9. PubMed ID: 8737752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered sympathetic and vagal modulations of the cardiovascular system in patients with pheochromocytoma: their relations to orthostatic hypotension.
    Munakata M; Aihara A; Imai Y; Noshiro T; Ito S; Yoshinaga K
    Am J Hypertens; 1999 Jun; 12(6):572-80. PubMed ID: 10371366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.